Statistical methods in immunology & rheumatology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Odds ratio
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Mixed-effects model
Logistic regression
MMRM (mixed model for repeated measures)
Risk difference
All immunology & rheumatology trials
1,062 results
- Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care: Complete Statistical AnalysisIndependent statistical analysis of Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Digital Knee Osteoarthritis Mindset Intervention: Complete Statistical AnalysisIndependent statistical analysis of Digital Knee Osteoarthritis Mindset Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05698368).
- DIRECTComplete statistical analysis of the DIRECT phase 3 trial of candesartan in participants with type 1 diabetes, including trial design, diabetic retinopathy progression, time-to-event methodology, hazard ratio interpretation, and safety.
- DIRECTComplete statistical analysis of the DIRECT trial of candesartan versus placebo in type 1 diabetes, including trial design, ETDRS retinopathy endpoint, log-rank analysis, hazard ratio, confidence interval, p-value, safety, and statistical interpretation.
- Discontinuing NSAIDs in Veterans With Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Discontinuing NSAIDs in Veterans With Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01799213).
- DIVERTIndependent statistical analysis of Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene: Complete Statistical AnalysisIndependent statistical analysis of Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DORAVIPEPIndependent statistical analysis of Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study: primary endpoint results, effect…
- Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DoseFlexIndependent statistical analysis of Dosing Flexibility Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580840).
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DPARTIndependent statistical analysis of Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04487145).
- dPEP-KEIndependent statistical analysis of Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DREAMIndependent statistical analysis of the DREAM phase 2 dose-ranging trial of intravenous mepolizumab in severe asthma, explaining the negative binomial regression, exacerbation rate ratios, confidence intervals and serious adverse events by dose.
- DREAMM 5Independent statistical analysis of Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM): primary endpoint results, effect estimate with confidence interval,…
- Driving Neuroplasticity With Nerve Stimulation and Modified CIT: Complete Statistical AnalysisIndependent statistical analysis of Driving Neuroplasticity With Nerve Stimulation and Modified CIT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02587234).
- Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients: Complete Statistical AnalysisIndependent statistical analysis of Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227395).
- Dymista Allergen Chamber – Onset of Action Study: Complete Statistical AnalysisIndependent statistical analysis of Dymista Allergen Chamber - Onset of Action Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04652245).
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E-TRaINIndependent statistical analysis of Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01426581).
- EASSIIndependent statistical analysis of EASSI - Evaluation of the Safety of Self-Administration With Icatibant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00997204).
- ECHELON-2Independent statistical analysis of ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas: primary endpoint results, effect estimate with confidence…
- EDICAn independent statistical analysis of the EDIC study in type 1 diabetes, covering its longitudinal design, registry-defined endpoints, planned time-to-event and longitudinal analyses, and statistical interpretation.
- EDITION IVIndependent statistical analysis of Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Effect of Benralizumab in Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Effect of Benralizumab in Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03563066).
- Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.: Complete Statistical AnalysisIndependent statistical analysis of Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Effect of Gain on Closed-Loop Insulin: Complete Statistical AnalysisIndependent statistical analysis of Effect of Gain on Closed-Loop Insulin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065895).
- Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00682357).
- Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting: Complete Statistical AnalysisIndependent statistical analysis of Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Effect of Raltegravir on Endothelial Function in HIV-Infected Patients: Complete Statistical AnalysisIndependent statistical analysis of Effect of Raltegravir on Endothelial Function in HIV-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00843713).
- Effect of Structured Info and Adapted Exercise in OA: Complete Statistical AnalysisIndependent statistical analysis of Effect of Structured Info and Adapted Exercise in OA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02022566).
- Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen: Complete Statistical AnalysisIndependent statistical analysis of Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00737204).
- Effectiveness of Chinese Herbal Therapy for Asthma: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Chinese Herbal Therapy for Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00712296).
- Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00118378).
- Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705793).
- Effectiveness of the Aeroneb in Acute Severe Asthma: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of the Aeroneb in Acute Severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029156).
- Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00075023).